Keywords
Metabolic syndrome, hemostasis condition, dyslipidemia
Abstract
Metabolic syndrome is one of the most critical problems in medicine. This is due, firstly, to the fact that this syndrome occurs in 25-35% of the world's population [1], and secondly, the risk of death from cardiovascular disease in patients with this syndrome is 2-3 times higher than in patients without metabolic syndrome, type 2 The risk of developing diabetes is 5-9 times higher [2]. The research was conducted at the Medical Association of Kagan, Bukhara region of the Republic of Uzbekistan, as a comparative study of clinical signs and laboratory parameters of patients with metabolic syndrome.